Status:
UNKNOWN
Previously Untreated Advanced Non-Small Cell Lung Cancer (NSCLC)
Lead Sponsor:
The Cooper Health System
Conditions:
Untreated Advanced Non-Small Cell Lung Cancer
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
Avastin is a novel antiangiogenic agent that has recently been shown to improve response rates and survival of patients with advanced nonsquamous non-small cell lung cancer when added to front-line ca...
Eligibility Criteria
Inclusion
- I am 18 years of age or older. I have advanced non-small lung cancer. I have not had any major surgical procedures within 28 days prior to my starting treatment.
- I have high blood pressure that is controlled. I am not on heparin, coumadin or lovonox for treatment of medical conditions. I do not have serious wound healing problems. I have not received any previous treatment, except radiation therapy for my disease.
Exclusion
- \-
Key Trial Info
Start Date :
Trial Type :
INTERVENTIONAL
End Date :
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00254319
Last Update
November 16 2005
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The CINJ at Cooper University Hospital
Voorhees Township, New Jersey, United States, 08043